EE04605B1 - Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks - Google Patents

Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks

Info

Publication number
EE04605B1
EE04605B1 EE9800382A EE9800382A EE04605B1 EE 04605 B1 EE04605 B1 EE 04605B1 EE 9800382 A EE9800382 A EE 9800382A EE 9800382 A EE9800382 A EE 9800382A EE 04605 B1 EE04605 B1 EE 04605B1
Authority
EE
Estonia
Prior art keywords
medicament
surfactant
plant
manufacture
treatment
Prior art date
Application number
EE9800382A
Other languages
English (en)
Estonian (et)
Other versions
EE9800382A (et
Inventor
Squires Meryl
Original Assignee
Squires Meryl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squires Meryl filed Critical Squires Meryl
Publication of EE9800382A publication Critical patent/EE9800382A/xx
Publication of EE04605B1 publication Critical patent/EE04605B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9800382A 1996-05-08 1997-03-12 Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks EE04605B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/646,988 US6355684B1 (en) 1990-10-11 1996-05-08 Antimicrobial treatment for herpes simplex virus and other infectious diseases
PCT/US1997/002468 WO1998011778A1 (en) 1996-05-08 1997-03-12 Antimicrobial treatment for herpes simplex virus and other infectious diseases

Publications (2)

Publication Number Publication Date
EE9800382A EE9800382A (et) 1999-04-15
EE04605B1 true EE04605B1 (et) 2006-04-17

Family

ID=24595254

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800382A EE04605B1 (et) 1996-05-08 1997-03-12 Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks

Country Status (30)

Country Link
US (2) US6355684B1 (de)
EP (1) EP0918458B1 (de)
JP (1) JP2001505546A (de)
KR (1) KR100347651B1 (de)
CN (1) CN1113599C (de)
AP (1) AP1356A (de)
AT (1) ATE349159T1 (de)
AU (1) AU716247B2 (de)
BG (1) BG64522B1 (de)
BR (1) BR9711086A (de)
CA (1) CA2253736C (de)
CZ (1) CZ295869B6 (de)
DE (1) DE69737144T2 (de)
DK (1) DK0918458T3 (de)
EA (1) EA001339B1 (de)
EE (1) EE04605B1 (de)
ES (1) ES2278393T3 (de)
GE (1) GEP20002132B (de)
HU (1) HU229230B1 (de)
IL (2) IL126924A (de)
IS (1) IS4888A (de)
NO (1) NO326139B1 (de)
NZ (1) NZ332650A (de)
OA (1) OA10917A (de)
PL (1) PL188470B1 (de)
RS (1) RS49721B (de)
SK (1) SK285361B6 (de)
TR (1) TR199802251T2 (de)
UA (1) UA65537C2 (de)
WO (1) WO1998011778A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US9662360B2 (en) * 2008-10-09 2017-05-30 Meritus Corporation Treatment of herpes, pseudomonas, staph, and hepatitis
CN1087608C (zh) * 1996-08-29 2002-07-17 中国人民解放军军事医学科学院放射医学研究所 二咖啡酰奎宁酸在治疗乙型肝炎及与逆转录病毒有关疾病中的用途及新咖啡酰奎宁酸衍生物
AU9578898A (en) 1997-09-24 1999-04-12 Geoffrey N Richards Composition and method for reducing pathogenic bacteria in food products
US6248343B1 (en) * 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
DE19814725A1 (de) * 1998-04-02 1999-10-07 Michael O Ruepp Verwendung von Echinacea-pallida und Echinacea angustifolia-Extrakten; Löwenzahn-/Taraxacum)-Extrakten; Spitzwegerich-(Plantago)-Extrakten
DE19814905A1 (de) * 1998-04-02 1999-10-07 Michael O Ruepp Aar Pharma Verwendung von Bärentraubenblätter (Arctostaphylos uva ursi)-, Birkenblätter (Betula)-, Schachtelhalmkraut (Equisetum)- und Brennessel (Urtica)-Extrakten
EP1076547A4 (de) 1998-04-27 2001-09-26 Larex Inc Arabinogalactanderivate und zusammenstellungen die diese enthalten
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
CA2379581C (en) * 1999-09-30 2011-03-22 Factors R & D Technologies Ltd. Echinacea supplement and method of manufacture
US6306443B1 (en) 2000-06-20 2001-10-23 Amway Corporation Method of increasing concentrations of caffeic acid derivatives and alkylamides and compositions containing the same
US6589513B2 (en) 2000-09-20 2003-07-08 Lesko-Care, L.L.C. Oral hygiene formulation and method of use
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
JP4280888B2 (ja) * 2001-03-23 2009-06-17 独立行政法人産業技術総合研究所 生分解性多価カルボン酸エステル・カルボン酸の製造方法
US6635679B2 (en) * 2001-05-14 2003-10-21 Akzo Nobel N.V. Methods and compositions for inactivating viruses
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US6767546B1 (en) * 2001-08-17 2004-07-27 The United States Of America As Represented By The Secretary Of Agriculture Use of echinacea as a feed additive to enhance protection against coccidiosis
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
DE10341579A1 (de) * 2003-09-09 2005-04-07 Bionorica Ag Verwendung von Extrakten aus Gentiana lutea als antimikrobiell wirkendes Mittel
GB0326520D0 (en) * 2003-11-13 2003-12-17 Compton Developments Ltd Molluscicidal and anti-barnacle compounds
DE102004005788A1 (de) * 2004-02-06 2005-09-01 Riemser Arzneimittel Ag Zubereitungen enthaltend Echinacea-Auszüge und Thiocyanat
AU2005259854C1 (en) * 2004-07-07 2011-06-02 Integria Healthcare (Australia) PTY LTD An Echinacea formulation
GB2432788C (en) * 2004-07-07 2018-06-27 Integria Healthcare Australia Pty Ltd An echinacea formulation
FR2877576B1 (fr) * 2004-11-08 2007-03-09 Ahmed Kadri Composition pharmaceutique utilisee pour stimuler la proliferation et l'activation des mastocytes
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
EP1671535A1 (de) * 2004-12-16 2006-06-21 Stiftung Caesar Center of Advanced European Studies and Research Verfahren zur Änderung des Gehaltes phenolischer Verbindungen in Pflanzenzellen
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US8809283B2 (en) 2005-05-20 2014-08-19 Natuderm, Llc Proteasome inhibitors and uses thereof
US7786176B2 (en) * 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
JP5513111B2 (ja) * 2006-07-20 2014-06-04 イズン ファーマシューティカルズ コーポレイション フィルム送達リンス
KR100791282B1 (ko) 2007-02-27 2008-01-04 재단법인 제주하이테크산업진흥원 미백활성을 나타내는 노루참나물 추출물
US20080241290A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Sinus relief composition and method of producing the same
US7850998B2 (en) * 2007-07-18 2010-12-14 Kiani Iraj E Method of treating viral conditions
US7700137B1 (en) 2007-07-18 2010-04-20 Kiani Iraj E Anti-viral compositions and method
US8637094B2 (en) * 2007-07-18 2014-01-28 Iraj E. Kiani Composition and method for treating viral conditions
US20090069446A1 (en) * 2007-09-06 2009-03-12 Wayne Jeffrey Perry Dendritic salt therapeutic agent delivery system
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
ITMI20080395A1 (it) 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
EP2278971A1 (de) * 2008-04-24 2011-02-02 Indena S.p.A. Zusammensetzungen zur behandlung von vaginalen infektionen mit chronischer entzündung
EP2320920B1 (de) 2008-07-22 2015-04-22 Izun Pharmaceuticals Corporation Topische entzündungshemmende kombination
ITRE20090011A1 (it) * 2009-02-11 2010-08-12 Gianni Magnanini Composizione terapeutica per il trattamento dell'herpes labialis
GB0917086D0 (en) * 2009-09-29 2009-11-11 Union Of Agricultural Cooperat Compositon of botanical extracts and their use
WO2011064292A2 (en) * 2009-11-25 2011-06-03 Dsm Ip Assets B.V. Polyester amide foamers
CN102844041A (zh) * 2010-01-11 2012-12-26 维托生物有限责任公司 用于治疗局部病毒感染的新协同组合物
US20110229537A1 (en) * 2010-03-17 2011-09-22 Arbonne International Llc Oral supplement
FR2969926B1 (fr) 2011-01-04 2017-03-10 Elicityl Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
EP2573085A1 (de) * 2011-09-26 2013-03-27 AiCuris GmbH & Co. KG N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamidmesylat-Monohydrat mit einem spezifischen Teilchengrößenverteilungsbereich und einem spezifischen Oberflächenbereich
CN103070918A (zh) * 2012-11-14 2013-05-01 翟立冬 一种可以清除hpv病毒的润体油及其制备方法
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
CN104138422A (zh) * 2013-05-09 2014-11-12 杨东天 一种治疗带状疱疹的中药制剂
CA2955981C (en) 2014-07-22 2022-10-25 Ralco Nutrition, Inc. Antiviral compositions comprising one or more essential oils
EP3034129A1 (de) 2014-12-16 2016-06-22 Agon Pharma GmbH Verfahren zur Herstellung eines Echinacea purpura Trockenpresssaftes und Verwendung desselben zur Behandlung von Equinem Sarkoid
CN105284945B (zh) * 2015-11-20 2018-12-04 黄乃宁 一种防治甘蔗凤梨病的方法
KR102670487B1 (ko) * 2016-11-17 2024-05-30 주식회사 엘지생활건강 시나린을 포함하는 구강질환 예방 또는 치료용 조성물
CN107898903A (zh) * 2017-10-12 2018-04-13 深圳职业技术学院 一种抗疱疹病毒的脂质体乳膏及其制备方法
WO2019108973A2 (en) * 2017-11-30 2019-06-06 Duke University Compositions and methods for ablating niche cells in testis and other epithelial cells and methods relating thereto
CN108030796A (zh) * 2017-12-18 2018-05-15 王秀兰 一种抗流感病毒的蒙药及其制备方法
US10478407B2 (en) 2018-02-23 2019-11-19 The Administrators Of The Tulane Educational Fund Pharmaceutical composition for viral infections
EA036150B1 (ru) * 2018-07-17 2020-10-05 Рамида Вагиф Кызы Шадлинская Средство для лечения и профилактики заболевания пародонта и слизистой ротовой полости
CZ307717B6 (cs) * 2018-08-01 2019-03-13 Fakultní nemocnice Hradec Králové 1-Alkyl-3-(2-hydroxyethyl)imidazolium-halogenid jako dezinfekční činidlo a dezinfekční kompozice, která jej obsahuje
US11931333B1 (en) 2019-05-28 2024-03-19 Peter Van Horn Topical treatment of herpes infections
CN114821176B (zh) * 2022-04-28 2022-11-01 浙江大学 一种儿童脑部mr图像病毒性脑炎分类系统
KR20240087518A (ko) 2022-12-01 2024-06-19 서울여자대학교 산학협력단 카페산을 포함하는 식물바이러스 방제용 조성물 및 이를 이용한 식물바이러스 방제 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935448A (en) 1983-01-10 1990-06-19 Baldone Joseph A Treatment of diseases caused by herpes viruses
US4760079A (en) 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US4661354A (en) 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
US4797420A (en) * 1984-08-14 1989-01-10 Jabco Manufacturing, Inc. Disinfectant formulation and method of use
US4585656A (en) 1984-08-20 1986-04-29 Rosenthal Harold R Treatment of herpes
EP0213099A3 (de) 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
FR2620698B1 (fr) * 1987-09-23 1990-08-10 Atlantic Pharma Prod Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires
US5149529A (en) 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
DE4017091A1 (de) 1990-05-27 1991-11-28 Walter Dr Mach Molekuelverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten
US6348503B1 (en) * 1996-02-12 2002-02-19 Meryl J. Squires Method and topical treatment composition for herpesvirus hominis
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US5461029A (en) 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
US5455033A (en) * 1993-05-21 1995-10-03 Degree/Silverman M.D. Inc. Medicinal composition for treatment of inflammation
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.

Also Published As

Publication number Publication date
IL165980A (en) 2010-06-30
KR100347651B1 (ko) 2002-11-30
DE69737144T2 (de) 2007-10-04
KR20000010847A (ko) 2000-02-25
CA2253736C (en) 2006-11-21
AP1356A (en) 2004-12-30
DK0918458T3 (da) 2007-05-07
WO1998011778A1 (en) 1998-03-26
RS49721B (sr) 2007-12-31
CZ359498A3 (cs) 1999-06-16
NO985200L (no) 1999-01-08
DE69737144D1 (de) 2007-02-08
CN1223546A (zh) 1999-07-21
EA199800893A1 (ru) 1999-06-24
EP0918458B1 (de) 2006-12-27
US6355684B1 (en) 2002-03-12
IL126924A (en) 2005-11-20
HUP9902055A2 (hu) 1999-12-28
UA65537C2 (en) 2004-04-15
CA2253736A1 (en) 1998-03-26
CN1113599C (zh) 2003-07-09
BG102984A (en) 1999-09-30
IS4888A (is) 1998-11-06
EE9800382A (et) 1999-04-15
ATE349159T1 (de) 2007-01-15
OA10917A (en) 2003-02-21
BR9711086A (pt) 2000-01-11
EA001339B1 (ru) 2001-02-26
JP2001505546A (ja) 2001-04-24
US6946490B2 (en) 2005-09-20
AP9801386A0 (en) 1998-12-31
TR199802251T2 (xx) 2001-06-21
US20030099726A1 (en) 2003-05-29
AU716247B2 (en) 2000-02-24
NO326139B1 (no) 2008-10-06
IL165980A0 (en) 2006-01-15
AU3715397A (en) 1998-04-14
YU50598A (sh) 2000-10-30
GEP20002132B (en) 2000-06-25
ES2278393T3 (es) 2007-08-01
PL188470B1 (pl) 2005-02-28
IL126924A0 (en) 1999-09-22
HU229230B1 (hu) 2013-09-30
NO985200D0 (no) 1998-11-06
EP0918458A1 (de) 1999-06-02
SK285361B6 (sk) 2006-11-03
CZ295869B6 (cs) 2005-11-16
NZ332650A (en) 1999-11-29
BG64522B1 (bg) 2005-06-30
PL330314A1 (en) 1999-05-10
EP0918458A4 (de) 2004-01-02
SK153398A3 (en) 1999-10-08
HUP9902055A3 (en) 2000-01-28

Similar Documents

Publication Publication Date Title
EE04605B1 (et) Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
IL114586A (en) Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
BR9508586A (pt) Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
EE9700039A (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
EE9700043A (et) Asendatud oksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
PL344223A1 (en) Compositions for the treatment of hiv and other viral infections
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
DE69510913D1 (de) Wegwerfwindel in höschenform
DE69510768D1 (de) Wegwerfwindel in höschenform
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
KR950702122A (ko) 기도부 바이러스 질환의 예방 및 치료제(Prophylactic and Remedy for Viral Diseases in Respiratory Tract)
EE9600018A (et) 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9600020A (et) 9-asendatud 2-(2-n-alkoksüfenüül)puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
NO983402L (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
IL97110A0 (en) Benzylphosphonic acid derivatives,compositions containing them and their use in treating viral diseases
FI961869A (fi) Rokotteen suunnittelu ja valmistus
EP0970189A4 (de) Ein in vitro modell für hiv und andere virale erkrankungen
HU913022D0 (en) Fibroplast increasing factor for treating and preventing virus caused diseases

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090312